Keyphrases
Safety Analysis
100%
Bladder Tumor
100%
Safety Self-efficacy
100%
Intermediate Risk
100%
Sedation
100%
Economic Analysis
100%
Efficacy Analysis
100%
Diode Laser Treatment
100%
Laser Therapy
66%
Laser Ablation
50%
Tumor
50%
Photodynamic Diagnosis
33%
Photodynamic
33%
Diode Laser
33%
Health Care Costs
16%
Free Treatment
16%
Stage Ta
16%
Urothelial Cancer
16%
Fluorescence-guided
16%
Late Follow-up
16%
Cystoscopy
16%
Non-muscle Invasive Bladder Cancer (NMIBC)
16%
Quality of Life Assessment
16%
Pain Management
16%
Dysuria
16%
Quality of Life Questionnaire
16%
High-score
16%
Hematuria
16%
Operating Theatre
16%
Visual Analog Scale
16%
Guided Biopsy
16%
Tumor Resection
16%
Tumor Surgery
16%
Pain Score
16%
Disease Course
16%
Medicine and Dentistry
Bladder Tumor
100%
Low Level Laser Therapy
100%
Outpatient
100%
Neoplasm
50%
Laser Surgery
50%
Cystoscopy
33%
Quality of Life
33%
Health Care Cost
33%
Dysplasia
16%
Non Muscle Invasive Bladder Cancer
16%
Cancer Surgery
16%
Biopsy Technique
16%
Strangury
16%
Urothelial Cancer
16%
Recurrent Disease
16%
Disease Course
16%
Hematuria
16%
Visual Analog Scale
16%